Skip to main content
. 2021 Sep 21;37(2):109814. doi: 10.1016/j.celrep.2021.109814

Figure 3.

Figure 3

P5C3 LS demonstrates potent neutralizing activity against SARS-CoV-2 VOCs

(A) Neutralization activity of mAbs performed in a live SARS-CoV-2 infectious virus cytopathic effect assay. The indicated SARS-CoV-2 variants were used to infect Vero E6 in vitro in the absence and presence of concentration response of the indicated mAb evaluated in duplicates or triplicates.

(B) Heatmap showing EC50 and EC80 neutralization potencies for the mAbs indicated in pseudoviral assay produced using the indicated mutated version of Spike. Results shown are the average of two to four independent experiments with each concentration response tested in duplicates or triplicates. Mean values ± SEM are shown.